Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Ophthalmology. Glaucoma|October 6, 2024
Relationships between Frailty and the Risk of Glaucoma in Middle-aged and Older AdultsJianqi Chen, Xu Cao, Xiaohua Zhuo, et al.Experimental Eye Research|July 11, 2024
Causal relationship between central corneal thickness and open-angle glaucoma: Evidence from Mendelian randomizationJianqi Chen, Xu Cao, Xiaohong Chen, et al.Journal of the American Geriatrics Society|November 14, 2023
Temporal trends and projection of blindness and vision loss prevalence in older adults in BRICS countriesJianqi Chen, Yingting Zhu, Zhidong Li, et al.Brain Research Bulletin|August 30, 2025
Altered Lateral Geniculate Nucleus Functional Connectivity and Its Correlation with Retinal Thickness in Primary Open-Angle Glaucoma: A Resting-State Functional MRI StudyXuhao Chen, Ning Wu, Shaofen Huang, et al.American Journal of Ophthalmology|September 20, 2025
Association Between Outdoor Daylight Exposure Duration and Primary Open-Angle GlaucomaJianqi Chen, Shaofen Huang, Xiaohua Zhuo, et al.Eclinicalmedicine|October 14, 2024
Global, regional, and national burden of retinoblastoma in infants and young children: findings from the global burden of disease study 1990-2021Jianqi Chen, Xu Cao, Shengsong Xu, et al.Journal of Neuroinflammation|April 7, 2023
N,N-Dimethyl-3β-hydroxycholenamide attenuates neuronal death and retinal inflammation in retinal ischemia/reperfusion injury by inhibiting Ninjurin 1Yunhong Shi, Yidan Liu, Caiqing Wu, et al.Proceedings of the National Academy of Sciences of the United States of America|April 24, 2024
Senolytic and senomorphic agent procyanidin C1 alleviates structural and functional decline in the aged retinaYidan Liu, Xiuxing Liu, Xuhao Chen, et al.Acta Diabetologica|May 22, 2024
Temporal trends in the visual impairment burden attributable to high fasting plasma glucose levels: a population-based studyJianqi Chen, Xiaohong Chen, Zhidong Li, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 24, 2023
Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor microenvironmentZhiqing Lin, Keke Huang, Hui Guo, et al.Pageof 5